MYC and medulloblastoma: While glucose metabolism in group 3 medulloblastomas and MycN-driven medulloblastomas in mice have yet to be investigated, it is likely that MYC reconfigures the metabolism to favor glycolysis in these tumors, as it does in other malignancies.